Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria-Reference-Cited by-同舟云学术

Time course of antiproteinuric effect of aliskiren in arterial hypertension associated with type 2 diabetes and microalbuminuria

Published:2013-02-17 Issue:4 Volume:14 Page:371-384
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Fogari Roberto¹,Mugellini Amedeo¹,Zoppi Annalisa¹,Preti Paola¹,Maffioli Pamela¹,Perrone Tiziano¹,Derosa Giuseppe¹

Affiliation:

1. University of Pavia, Clinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, Piazzale Golgi 19, 27100 Pavia, Italy ; ;

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/14656566.2013.772981

Reference52 articles.

1. Hypertension and antihypertensive treatment of diabetic nephropathy

2. Molecular Mechanisms of Diabetic Nephropathy and Its Therapeutic Intervention

3. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

4. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria

5. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease;Kidney International;2021-03

2. Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertension;Cochrane Database of Systematic Reviews;2020-10-22

3. Efficacy and Safety of Imarikiren in Patients with Type 2 Diabetes and Microalbuminuria;Clinical Journal of the American Society of Nephrology;2019-02-12